Considering the established oncogenic roles of CEACAM5, it is reasonable to speculate that SMOC2-induced CEACAM5 down-regulation may contribute to a tumor suppressive role of SMOC2 in CRC progression. This evidence concerns the gene CEACAM5 and colorectal carcinoma.